Dianorm 1 mg tablet is a medicine made by Rephco Pharmaceuticals Ltd. It may also be prescribed together with metformin for better control.
There are 15 brands of Repaglinide listed in Bangladesh. 4 of them have a lower unit price than Dianorm. The lowest listed price is Singlin 1 mg Tablet at ৳ 3.00 per unit.
What is Dianorm 1 mg Tablet?
Made by Rephco Pharmaceuticals Ltd., Dianorm is a tablet whose active ingredient is Repaglinide. Dianorm 1 mg tablet is a meglitinide analogue, a type of oral blood sugar-lowering medicine. It can be used alone or with metformin. Always follow your doctor's instructions regarding dose and timing, as these are individualized.
Uses of Dianorm
It may also be prescribed together with metformin for better control. It may also be prescribed in combination with metformin when blood sugar remains high despite treatment. It can also be used together with metformin in some patients. Ask your doctor whether this medicine is suitable for your condition.
How to use Dianorm
Take Dianorm exactly as your doctor tells you. Swallow the tablet with water. Dianorm is taken by mouth. The tablet can be taken with or without food. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Dianorm
If you experience any side effects, contact your doctor or pharmacist for advice. The most common side effect of Dianorm 1 mg tablet is low blood sugar (hypoglycemia), which can cause symptoms like shaking, sweating, and confusion. Tell your doctor if any side effect bothers you or does not go away. Do not stop or change your medicine without consulting your doctor.
Safety and precautions
During illness, surgery, or trauma, insulin may be needed instead; your doctor will advise. Consult your doctor before use if you are pregnant, planning pregnancy, or breastfeeding. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does Dianorm treat?
It may also be prescribed together with metformin for better control. It may also be prescribed in combination with metformin when blood sugar remains high despite treatment.
How is Dianorm used?
Take Dianorm exactly as your doctor tells you. Swallow the tablet with water.
Can Dianorm cause side effects?
If you experience any side effects, contact your doctor or pharmacist for advice. The most common side effect of Dianorm 1 mg tablet is low blood sugar (hypoglycemia), which can cause symptoms like shaking, sweating, and confusion.
Repaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in combination with Metformin to lower blood glucose ... Read moreRepaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in combination with Metformin to lower blood glucose in patients whose hyperglycemia cannot be controlled by exercise, diet, and either Repaglinide or Metformin alone.
Pharmacology
Repaglinide binds to specific receptors in the cell membrane leading to the closure of ATP dependent K+ channels and the depolarisation of cell membrane. This in turn, leads to Ca++ influx, increased intracellular Ca++ and the stimulation of insulin secretion.
Dosage & Administration
For patients not previously treated or whose HbA1c is <8%, the starting dose should be 0.5 mg before each meal.
For patients previously treated with blood glucose-lowering drugs and whose HbA1c is >8%, the initial dose is 1 or 2 mg before each meal.
Repaglinide should be taken immediately or up to 30 minutes before each meal.
Dosage should be adjusted according to response at intervals of 1-2 weeks; up to 4 mg may be given as a single-dose, maximum 16 mg daily.
Interaction
The dose of Repaglinide may need to be adjusted, if taken with other medications. The possible interactions of Repaglinide with other drugs are:
Inhibitors of the cytochrome P450 enzyme system (azole antifungals and macrolides) may lead to lower Repaglinide clearance and longer half life.
Inducers of the cytochrome P450 enzyme system (Rifampin, Phenobarbital, Carbamazepine, Troglitazone, etc.) may accelerate Repaglinide metabolism and shorten its effect.
Cimetidine has no significant effect on Repaglinide absorption or clearance.
Repaglinide has no significant effect on Digoxin, Theophyllin, or Warfarin.
Highly protein bound drugs (e.g., NSAIDs) may increase the plasma level of unbound Repaglinide and potentiate its glucose lowering effect. Thus, co-administration of these drugs with Repaglinide may increase the risk of hypoglycaemia.
The risk of hypoglycaemia may also be increased when hypoglycaemic agents are co-administered with certain drugs such as salicylates, sulphonamides, Chloramphenicol, coumarins, Probenecid, monoamine oxidase (MAO) inhibitors, and adrenergic blockers.
Contraindications
Repaglinide is contraindicated in patients with:
Diabetic ketoacidosis, with or without coma.
Type 1 diabetes mellitus and
Known hypersensitivity to the drug or its inactive ingredients.
Side Effects
The most common side effects of Repaglinide are hypoglycemia and related symptoms. Others include upper respiratory tract infections, diarrhea, constipation, nausea and vomiting. Hypersensitivity reactions include rashes and urticaria.
Pregnancy & Lactation
Safety in pregnant women has not been established. Repaglinide should be used during pregnancy only if it is clearly needed. It is not known whether Repaglinide is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Repaglinide, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
Insulin should be substituted during concurrent illness (such as myocardial infarction, coma, infection, and trauma) and during surgery. All oral blood glucose-lowering drugs are capable of producing hypoglycemia. Repaglinide should be administered with meals to lessen the risk of hypoglycemia.
Overdose Effects
Patients receiving up to 80 mg of Repaglinide developed few adverse effects other than lowering of blood glucose. Hypoglycemia did not occur when meals were given with these high doses. Severe hypoglycemic reactions with coma, seizure or other neurological impairment occur infrequently.
Storage Conditions
Do not store above 30°C. Keep away from light and out of the reach of children.
Alternative brands of Repaglinide
Other brands with the same generic name, cheapest first.